Psoriatic Arthritis News

Among patients with psoriatic disease, poor sleep quality was prevalent and associated with fatigue, anxiety and lower EuroQol-5D scores, according to findings.esearchers evaluated consecutive patients seen Toronto Western Hospital’s treatment center for psoriatic arthritis (PsA n=113) and for psoriasis without psoriatic arthritis (PsC, n=62) during the course of 3 months. Additionally, they recruited 52 controls from a pool of healthy volunteers who had agreed to participate in the parent International Psoriasis and Arthritis Research Team (IPART) study.

Among patients with recent-onset arthritis, roughly one-fourth develop chronic inflammatory rheumatic disease after 2 years, according to findings.

The common-sense model of self-regulation, or CSM, appears to be a useful means of accounting for disparities in psychological outcomes in patients with psoriatic arthritis, according to findings.

The FDA has approved the second biosimilar to Humira, Cyltezo, for several gastroenterological, rheumatological and dermatological indications.

Among patients with psoriatic arthritis, structural damage impacted physical function, according to a recently published study.

ORLANDO, Fla. — At the Rheumatology Nurses Annual Conference, Iris Zink, MSN, RN, ANP-BC, RN-BC, spoke about inflammation in patients with rheumatic diseases and how one can control it naturally. She said it is important for rheumatology health care providers to educate patients on the importance of diet, exercise, movement, meditation, acupuncture, sleep and limiting stress.

The FDA Arthritis Advisory Committee voted 10-1 today for recommending approval of the supplemental new drug application for tofacitinib in the treatment of adult patients with active psoriatic arthritis.

Healio Rheumatology presents the five top stories in psoriatic arthritis.

According to a recently published study, MRI can be useful in the evaluation of patients with psoriatic arthritis.

The European Commission has approved Bristol Myers-Squibb’s Orencia for patients with active psoriatic arthritis, according to a company press release.